findmyKOL

Shadwan Alsafwah, MD

Basic profile

Interventional Cardiology

ORCIDNPI
RegionHazel Crest, IL · MidwestSpecialtyInterventional CardiologyFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2022Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Shadwan Alsafwah is a Cardiology physician. OpenAlex indexes 51 publications with 331 citations (h-index 8).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
51publications

Distinct works indexed by OpenAlex, matched via ORCID.

331citations

Total citations across indexed works.

8h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
22companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

17850 Kedzie Ave Ste 3250
Hazel Crest, IL 604292082

Telephone

708-799-8700

Provider last certified this registry record 31 Aug 2022.

View the NPPES registry record

Industry payments

22 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    68.7%
    Beta blocker17.5%
    Metoprolol Succinate51%Carvedilol28%Metoprolol Tartrate21%
    Part D29 patients
    Calcium channel blocker10.6%
    Amlodipine Besylate66%Nifedipine Er34%
    Part D<11 patients

    + 10 more classes in this area

  • Blood & clotting

    25.6%
    P2Y12 inhibitor12.9%
    Clopidogrel54%Brilinta46%
    Part D28 patients
    Factor Xa inhibitor10.9%
    Eliquis76%Xarelto24%
    Part D<11 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    5.7%
    SGLT2 inhibitor5.7%
    Jardiance100%
    Part D11 patients
Where care is delivered (Part B)92.3% facility · 7.7% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”